Not logged in Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial Karimi, Yasmin H.; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Farooq, Umar; Feldman, Tatyana; Ghesquieres, Herve; Jurczak, Wojciech; Linton, Kim M.; Phillips, Tycel; Vose, Julie M.; Kim, Won Seog; Jafarinasabian, Pegah; D'angelo Mansson, Barbara; Soong, David; Steele, Andrew J.; Li, Zhu; Eskelund, Christian W.; Hutchings, Martin; Thieblemont, Catherine Share Save
Epcoritamab in Japanese patients with relapsed/refractory diffuse large B-cell lymphoma: EPCORE NHL-3 longer-term data Izutsu, K.; Kumode, T.; Yuda, J.; Nagai, H.; Mishima, Y.; Suehiro, Y.; Yamamoto, K.; Fujisaki, T.; Ishitsuka, K.; Ishizawa, K.; Ikezoe, T.; Nishikori, M.; Akahane, D.; Fujita, J.; Jafarinasabian, P.; Noguchi, H.; Buchbjerg, J.; Favaro, E.; Fukuhara, N. Share Save
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer Strickler, J. H.; Satake, H.; George, T. J.; Yaeger, R.; Hollebecque, A.; Garrido-Laguna, I.; Schuler, M.; Burns, T. F.; Coveler, A. L.; Falchook, G. S.; Vincent, M.; Sunakawa, Y.; Dahan, L.; Bajor, D.; Rha, S. -Y.; Lemech, C.; Juric, D.; Rehn, M.; Ngarmchamnanrith, G.; Jafarinasabian, P.; Tran, Q.; Hong, D. S. Share Save
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval Cadieux, Benoit; Coleman, Robert; Jafarinasabian, Pegah; Lipton, Allan; Orlowski, Robert Z.; Saad, Fred; Scagliotti, Giorgio, V; Shimizu, Kazuyuki; Stopeck, Alison Share Save
A phase 1b study evaluating the safety and efficacy of sotorasib, a KRASG12C inhibitor, in combination with trametinib, a MEK inhibitor, in KRAS p.G12C-Mutated Solid Tumors Ramalingam, Suresh; Fakih, Marwan; Strickler, John; Govindan, Ramaswamy; Li, Bob T.; Goldberg, Sarah; Gandara, David; Burns, Timothy; Barve, Minal; Shu, Catherine; Frank, Richard; Sohal, Davendra; Jafarinasabian, Pegah; Dai, Tian; Mather, Omar; Hong, David Share Save
Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model Trivedi, Ashit; Sohn, Winnie; Kulkarni, Priyanka; Jafarinasabian, Pegah; Zhang, Hanze; Spring, Marintan; Flach, Stephen; Abbasi, Siddique; Wahlstrom, Jan; Lee, Edward; Dutta, Sandeep Share Save
Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations Trivedi, Ashit; Hsu, Cheng-Pang; Jafarinasabian, Pegah; Terminello, Bianca; Zhang, Hanze; Flach, Stephen; Israel, Samuel; Brooks, Ashley; Xue, Hongqi; Darpo, Borje; Abbasi, Siddique; Dutta, Sandeep; Lee, Edward Share Save
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma Smith, David C.; Kroiss, Matthias; Kebebew, Electron; Habra, Mouhammed Amir; Chugh, Rashmi; Schneider, Bryan J.; Fassnacht, Martin; Jafarinasabian, Pegah; Ijzerman, M. Marian; Lin, Vivian H.; Mohideen, Pharis; Naing, Aung Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
